Terms: = Lung cancer AND GATA1, ERYF1, P15976, 2623, ENSG00000102145, NFE1, GF1
24 results:
1. Conteltinib (CT-707) in patients with advanced ALK-positive non-small cell lung cancer: a multicenter, open-label, first-in-human phase 1 study.
Xing P; Zhao Q; Zhang L; Wang H; Huang D; Hu P; Sun Y; Shi Y
BMC Med; 2022 Nov; 20(1):453. PubMed ID: 36424628
[TBL] [Abstract] [Full Text] [Related]
2. Hyperglycemia-induced oxidative stress promotes tumor metastasis by upregulating vWF expression in endothelial cells through the transcription factor gata1.
Jeong HS; Lee DH; Kim SH; Lee CH; Shin HM; Kim HR; Cho CH
Oncogene; 2022 Mar; 41(11):1634-1646. PubMed ID: 35094008
[TBL] [Abstract] [Full Text] [Related]
3. BCL11A enhancer-edited hematopoietic stem cells persist in rhesus monkeys without toxicity.
Demirci S; Zeng J; Wu Y; Uchida N; Shen AH; Pellin D; Gamer J; Yapundich M; Drysdale C; Bonanno J; Bonifacino AC; Krouse AE; Linde NS; Engels T; Donahue RE; Haro-Mora JJ; Leonard A; Nassehi T; Luk K; Porter SN; Lazzarotto CR; Tsai SQ; Weiss MJ; Pruett-Miller SM; Wolfe SA; Bauer DE; Tisdale JF
J Clin Invest; 2020 Dec; 130(12):6677-6687. PubMed ID: 32897878
[TBL] [Abstract] [Full Text] [Related]
4. Independent risk factors for lymph node metastasis in 2623 patients with Non-Small cell lung cancer.
Xue X; Zang X; Liu Y; Lin D; Jiang T; Gao J; Wu C; Ma X; Deng H; Yu Z; Pan L; Xue Z
Surg Oncol; 2020 Sep; 34():256-260. PubMed ID: 32891339
[TBL] [Abstract] [Full Text] [Related]
5. A Platelet Function Modulator of Thrombin Activation Is Causally Linked to Cardiovascular Disease and Affects PAR4 Receptor Signaling.
Rodriguez BAT; Bhan A; Beswick A; Elwood PC; Niiranen TJ; Salomaa V; ; Trégouët DA; Morange PE; Civelek M; Ben-Shlomo Y; Schlaeger T; Chen MH; Johnson AD
Am J Hum Genet; 2020 Aug; 107(2):211-221. PubMed ID: 32649856
[TBL] [Abstract] [Full Text] [Related]
6. Whole-genome fingerprint of the DNA methylome during chemically induced differentiation of the human AML cell line HL-60/S4.
Antwi EB; Olins A; Teif VB; Bieg M; Bauer T; Gu Z; Brors B; Eils R; Olins D; Ishaque N
Biol Open; 2020 Feb; 9(2):. PubMed ID: 31988093
[TBL] [Abstract] [Full Text] [Related]
7. Sp1 Mediates the Constitutive Expression and Repression of the PDSS2 Gene in lung cancer Cells.
Hu L; Chen Q; Wang Y; Zhang N; Meng P; Liu T; Bu Y
Genes (Basel); 2019 Nov; 10(12):. PubMed ID: 31783675
[TBL] [Abstract] [Full Text] [Related]
8. A MYC target long non-coding RNA GATA2-AS1 regulates non-small cell lung cancer growth.
Zhang L; Gao L; Shao M; Sun GY
Neoplasma; 2019 Nov; 66(6):954-962. PubMed ID: 31607132
[TBL] [Abstract] [Full Text] [Related]
9. Decision-Making Capacity for Chemotherapy and Associated Factors in Newly Diagnosed Patients with lung cancer.
Ogawa A; Kondo K; Takei H; Fujisawa D; Ohe Y; Akechi T
Oncologist; 2018 Apr; 23(4):489-495. PubMed ID: 29212735
[TBL] [Abstract] [Full Text] [Related]
10. Down-regulated GATA-1 up-regulates interferon regulatory factor 3 in lung adenocarcinoma.
Wang LL; Chen ZS; Zhou WD; Shu J; Wang XH; Jin R; Zhuang LL; Hoda MA; Zhang H; Zhou GP
Sci Rep; 2017 May; 7(1):2551. PubMed ID: 28566697
[TBL] [Abstract] [Full Text] [Related]
11. E2F and GATA switches turn off WD repeat domain 77 expression in differentiating cells.
Yu M; Wang U; Wang Z
Biochem J; 2016 Aug; 473(15):2331-43. PubMed ID: 27274086
[TBL] [Abstract] [Full Text] [Related]
12. Molecular testing patterns in metastatic non-small cell lung cancer.
MacLean E; Louder A; Saverno K; Smith G; Mardekian J; Brunis C; Ward M; Sweetman R; Pasquale M
Am J Manag Care; 2016 Feb; 22(2):e60-7. PubMed ID: 26881321
[TBL] [Abstract] [Full Text] [Related]
13. Integrated analyses of copy number variations and gene differential expression in lung squamous-cell carcinoma.
Yang Z; Zhuan B; Yan Y; Jiang S; Wang T
Biol Res; 2015 Aug; 48(1):47. PubMed ID: 26297502
[TBL] [Abstract] [Full Text] [Related]
14. Synthesis, docking and ADMET studies of novel chalcone triazoles for anti-cancer and anti-diabetic activity.
Chinthala Y; Thakur S; Tirunagari S; Chinde S; Domatti AK; Arigari NK; K V N S S; Alam S; Jonnala KK; Khan F; Tiwari A; Grover P
Eur J Med Chem; 2015 Mar; 93():564-73. PubMed ID: 25743216
[TBL] [Abstract] [Full Text] [Related]
15. Birth weight and adult cancer incidence: large prospective study and meta-analysis.
Yang TO; Reeves GK; Green J; Beral V; Cairns BJ;
Ann Oncol; 2014 Sep; 25(9):1836-1843. PubMed ID: 25015335
[TBL] [Abstract] [Full Text] [Related]
16. Association between single nucleotide polymorphism of PD-L1 gene and non-small cell lung cancer susceptibility in a Chinese population.
Chen YB; Mu CY; Chen C; Huang JA
Asia Pac J Clin Oncol; 2014 Jun; 10(2):e1-6. PubMed ID: 23167931
[TBL] [Abstract] [Full Text] [Related]
17. Identification of STAT3-independent regulatory effects for protein inhibitor of activated STAT3 by binding to novel transcription factors.
Dabir S; Kluge A; Aziz MA; Houghton JA; Dowlati A
Cancer Biol Ther; 2011 Jul; 12(2):139-51. PubMed ID: 21532337
[TBL] [Abstract] [Full Text] [Related]
18. Cardiac or cardiopulmonary transplantation in childhood cancer survivors: an increasing need?
Levitt G; Anazodo A; Burch M; Bunch K
Eur J Cancer; 2009 Nov; 45(17):3027-34. PubMed ID: 19744853
[TBL] [Abstract] [Full Text] [Related]
19. Induction of signalling in non-erythroid cells by pharmacological levels of erythropoietin.
Dunlop EA; Percy MJ; Boland MP; Maxwell AP; Lappin TR
Neurodegener Dis; 2006; 3(1-2):94-100. PubMed ID: 16909043
[TBL] [Abstract] [Full Text] [Related]
20. Identification of novel functional sequence variants in the gene for peptidase inhibitor 3.
Chowdhury MA; Kuivaniemi H; Romero R; Edwin S; Chaiworapongsa T; Tromp G
BMC Med Genet; 2006 May; 7():49. PubMed ID: 16719916
[TBL] [Abstract] [Full Text] [Related]
[Next]
